Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/7369
DC FieldValueLanguage
dc.contributor.authorVeljanoska, S.en_US
dc.contributor.authorKlisarovska, V.en_US
dc.contributor.authorArsovski, O.en_US
dc.contributor.authorBasevska, N.en_US
dc.contributor.authorStojkovski, Igoren_US
dc.contributor.authorSimonova, D.en_US
dc.date.accessioned2020-03-24T13:59:17Z-
dc.date.available2020-03-24T13:59:17Z-
dc.date.issued2011-09-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/7369-
dc.language.isoenen_US
dc.publisherElsevier BVen_US
dc.relation.ispartofEuropean Journal of Canceren_US
dc.subjectCapecitabine Chemotherapyen_US
dc.subjectEpithelial Ovarian Canceren_US
dc.title8034 POSTER Capecitabine as Second- and Third-line Chemotherapy in the Treatment of Platinum-refractory Epithelial Ovarian Canceren_US
dc.typeProceeding articleen_US
dc.identifier.doi10.1016/s0959-8049(11)72122-0-
dc.identifier.urlhttps://api.elsevier.com/content/article/PII:S0959804911721220?httpAccept=text/xml-
dc.identifier.urlhttps://api.elsevier.com/content/article/PII:S0959804911721220?httpAccept=text/plain-
dc.identifier.volume47-
dc.identifier.fpageS537-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Show simple item record

Page view(s)

19
checked on Aug 8, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.